Exenatide (exendin-4) studies: 530 papers with results
Page 11 of 11
- Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.
Ray JA · Current medical research and opinion · 2007
Not a test of Exenatide (exendin-4) alone · 5 results
- Case report of acute necrotizing pancreatitis associated with combination treatment of sitagliptin and exenatide.
Iyer SN · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2012
Not a test of Exenatide (exendin-4) alone · 5 results
- Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation.
Yu M · Clinical therapeutics · 2016
Not a test of Exenatide (exendin-4) alone · 9 results
- Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US.
Samyshkin Y · Journal of medical economics · 2012
Not a test of Exenatide (exendin-4) alone · 5 results
- Acute renal failure when exenatide is co-administered with diuretics and angiotensin II blockers.
López-Ruiz A · Pharmacy world & science : PWS · 2010
Not a test of Exenatide (exendin-4) alone · 5 results
- Prophylactic use of anti-emetic medications reduced nausea and vomiting associated with exenatide treatment: a retrospective analysis of an open-label, parallel-group, single-dose study in healthy subjects.
Ellero C · Diabetic medicine : a journal of the British Diabetic Association · 2010
Not a test of Exenatide (exendin-4) alone · 5 results
- Activin A, exendin-4, and glucose stimulate differentiation of human pancreatic ductal cells.
Kim HS · The Journal of endocrinology · 2013
Not a test of Exenatide (exendin-4) alone · 5 results
- Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study.
Abdul-Ghani M · Diabetes, obesity & metabolism · 2020
Not a test of Exenatide (exendin-4) alone · 5 results
- Dapagliflozin plus exenatide on patients with type 2 diabetes awaiting bariatric surgery in the DEXBASU study.
López-Cano C · Scientific reports · 2022
Not a test of Exenatide (exendin-4) alone · 5 results
- Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutide.
Alatorre C · Diabetes, obesity & metabolism · 2017
Not a test of Exenatide (exendin-4) alone · 8 results
- Interspecies modeling and prediction of human exenatide pharmacokinetics.
Chen T · Pharmaceutical research · 2013
Not a test of Exenatide (exendin-4) alone · 4 results
- The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m(2) in Spain.
Fonseca T · Journal of medical economics · 2013
Not a test of Exenatide (exendin-4) alone · 4 results
- Cost-effectiveness analysis of liraglutide versus sitagliptin or exenatide in patients with inadequately controlled Type 2 diabetes on oral antidiabetic drugs in Greece.
Tzanetakos C · BMC health services research · 2014
Not a test of Exenatide (exendin-4) alone · 12 results
- Cost-effectiveness analysis of exenatide twice daily (BID) vs insulin glargine once daily (QD) as add-on therapy in Chinese patients with Type 2 diabetes mellitus inadequately controlled by oral therapies.
Deng J · Journal of medical economics · 2015
Not a test of Exenatide (exendin-4) alone · 4 results
- Efficacy of Exenatide Plus Pioglitazone Vs Basal/Bolus Insulin in T2DM Patients With Very High HbA1c.
Abdul-Ghani M · The Journal of clinical endocrinology and metabolism · 2017
Not a test of Exenatide (exendin-4) alone · 4 results
- Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial.
Abdul-Ghani MA · Diabetes, obesity & metabolism · 2015
Not a test of Exenatide (exendin-4) alone · 3 results
- Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study.
Hari Kumar KV · Diabetes research and clinical practice · 2013
Not a test of Exenatide (exendin-4) alone · 3 results
- Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study.
Chedid V · Neurogastroenterology and motility · 2018
Not a test of Exenatide (exendin-4) alone · 7 results
- Cost-utility of exenatide once weekly compared with insulin glargine in patients with type 2 diabetes in the UK.
Beaudet A · Journal of medical economics · 2011
Not a test of Exenatide (exendin-4) alone · 3 results
- Treatment with glucagon-like Peptide-1 agonist exendin-4 in a patient with hypothalamic obesity secondary to intracranial tumor.
Simmons JH · Hormone research in paediatrics · 2012
Not a test of Exenatide (exendin-4) alone · 3 results
- Combination therapy with exenatide decreases the dapagliflozin-induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial.
van Ruiten CC · Diabetes, obesity & metabolism · 2022
Not a test of Exenatide (exendin-4) alone · 3 results
- The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France.
Basson M · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2018
Not a test of Exenatide (exendin-4) alone · 7 results
- Cost-Utility Analysis of Once-Weekly Semaglutide, Dulaglutide, and Exenatide for Type 2 Diabetes Patients Receiving Metformin-Based Background Therapy in China.
Hu S · Frontiers in pharmacology · 2022
Not a test of Exenatide (exendin-4) alone · 13 results
- Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study.
Abdul-Ghani M · Diabetes, obesity & metabolism · 2018
Not a test of Exenatide (exendin-4) alone · 3 results
- Exenatide and glucagon co-infusion increases myocardial glucose uptake and improves markers of diastolic dysfunction in adults with type 2 diabetes.
Goodman J · Scientific reports · 2025
Not a test of Exenatide (exendin-4) alone · 3 results
- The glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticles.
Li X · Pharmaceutical research · 2015
Not a test of Exenatide (exendin-4) alone · 2 results
- Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled type 2 diabetes in the United Kingdom.
Woehl A · Cardiovascular diabetology · 2008
Not a test of Exenatide (exendin-4) alone · 2 results
- In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.
Wu Z · Bioconjugate chemistry · 2011
Not a test of Exenatide (exendin-4) alone · 1 result
- Population pharmacokinetics of liraglutide, a once-daily human glucagon-like peptide-1 analog, in healthy volunteers and subjects with type 2 diabetes, and comparison to twice-daily exenatide.
Watson E · Journal of clinical pharmacology · 2010
Not a test of Exenatide (exendin-4) alone · 5 results
- Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide.
Savvidou S · Diabetes research and clinical practice · 2016
Not a test of Exenatide (exendin-4) alone · 1 result